Comparing Nicardipine and Clevidipine in Neurocritical Care

This chapter explores the critical debate surrounding the use of nicardipine versus clevidipine for blood pressure management in neurocritical care, particularly for patients with ischemic strokes and intracerebral hemorrhages. It discusses clinical efficacy, pharmacokinetic differences, and the implications of medication costs on treatment choices and outcomes. Additionally, the chapter highlights research findings on the importance of rapid blood pressure control for improving patient outcomes.